Khan Najat bought RXRX
February 3, 2025 · Form 4 insider transaction
Khan Najat bought 210,113 shares of Recursion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
210,113
Price
$0.00
Total value
N/A
InsiderKhan Najat
Role—
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateFebruary 3, 2025
Filing dateFebruary 5, 2025
Shares owned after707,085
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2025 and every three months thereafter.